Innovations
We turn an idea into a funded, connected, de-risked opportunity — ecosystem strategy, EU consortium building, funding pipelines, and AI-assisted impact and market intelligence.
Regeneering and Loonshot Factory run their own sites; Ikigaia Innovations works at the group level. Each carries the Ikigaia name — step into any of them, or let the group route the whole journey.
We turn an idea into a funded, connected, de-risked opportunity — ecosystem strategy, EU consortium building, funding pipelines, and AI-assisted impact and market intelligence.
Our own precommercial pilot platform, built on a once-idled industrial site brought back to life. A full pulping-to-forming line and an in-house ISO/TAPPI lab — where a material is proven from bench to production line before a euro is committed.
The EPCM and scale-up partner for biobased, circular and energy-transition manufacturing — de-risking first-of-kind, small-to-mid-cap projects (<€50M) from concept to a running plant, and staying on site to performance.
The group parent: governance, group-level advisory, and the capital relationships that surface deal flow for the whole pipeline — so every pilot feeds a scale-up, and every win feeds the next.
Three capabilities that hand off cleanly across the scale-up journey, and one group that closes the loop.
Turns an idea into a funded, connected, de-risked opportunity.
Proves the material on a real line before a euro of capital is committed.
Engineers, builds and commissions the plant that makes it real.
Group advisory and capital — the flywheel that turns success into the next crossing.
Innovations is the group's ecosystem and capital capability. It works at the start of the journey: finding the idea, building the consortium, securing the funding, and connecting the capital that lets Loonshot prove it and Regeneering build it.
Regional innovation platforms and TKI strategy — turning public ambition into a concrete, self-financing plan that industry and startups actually use.
Horizon Europe and national instruments, concept to submission — with real multi-partner consortium credibility behind the applications.
AI-assisted, evidence-first analysis of markets, feedstocks and policy — the rigour Regeneering brings to engineering, applied to the opportunity.
The bridge between de-risked evidence and the funds that back it — surfacing and qualifying deal flow across the whole group.